Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA

Mitsunori Ushigome,Hideaki Shimada,Yasuyuki Miura,Kimihiko Yoshida,Tomonori Kaneko,Takamaru Koda,Yasuo Nagashima,Takayuki Suzuki,Satoru Kagami,Kimihiko Funahashi

Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA

2019

Mitsunori Ushigome
Hideaki Shimada
Yasuyuki Miura
Kimihiko Yoshida
Tomonori Kaneko
Takamaru Koda
Yasuo Nagashima
Takayuki Suzuki
Satoru Kagami
Kimihiko Funahashi

Background The clinical impact of monitoring serum p53 antibodies, carbohydrate antigen19-9, and carcinoembryonic antigen in patients with colorectal cancer has not been fully evaluated.

Keywords:

Pathology
Antibody
Gastroenterology
Medicine
Colorectal cancer
Carcinoembryonic antigen
Recurrent Colorectal Cancer
Internal medicine
CA19-9
Disease
p53 antibodies
Surgical oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations